Saturday, July 11, 2026

Drug profile · INN

mechlorethamine hydrochloride

mechlorethamine hydrochloride (MUSTARGEN) is a dna inhibitor. Route of administration: topical. Current US regulatory status: approved.

FDA: approved
US status approved
Patents linked 0
Pipeline programs 0
News articles 0
Drug details — mechlorethamine hydrochloride
US status
approved
Class
Route
TOPICAL
Patents
0
Programs
0
Data quality
0.84

Quick answer

mechlorethamine hydrochloride (MUSTARGEN) is a dna inhibitor. Route of administration: topical. Current US regulatory status: approved.

Key facts

INN mechlorethamine hydrochloride
Brand MUSTARGEN
Mechanism DNA inhibitor
Target DNA
Route TOPICAL
Formulation INJECTABLE

Mechanism of action

DNA inhibitor

Primary target: DNA

Approval history

Authority Status Date
FDA approved

Related & competitor drugs

  1. acyclovir Human herpesvirus 1 DNA polymerase inhibitor
  2. acyclovir sodium Human herpesvirus 1 DNA polymerase inhibitor
  3. azacitidine Antineoplastic and immunomodulating agents (L01)
  4. bleomycin sulfate DNA inhibitor
  5. busulfan Antineoplastic and immunomodulating agents (L01)
  6. capecitabine Antineoplastic and immunomodulating agents (L01)

Frequently asked questions

What is mechlorethamine hydrochloride?

mechlorethamine hydrochloride (MUSTARGEN) is a dna inhibitor. Route of administration: topical. Current US regulatory status: approved.

What is the brand name for mechlorethamine hydrochloride?

MUSTARGEN is a marketed brand name for mechlorethamine hydrochloride. Check FDA Drugs@FDA for the current US label holder and prescribing information.

What is the US approval status of mechlorethamine hydrochloride?

mechlorethamine hydrochloride has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.